Back to Search
DONALD BROPHY, PHARM.D.
PHARM.D.
Pharmacotherapy Pharmacist
NPI: 1376621326Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
0202012316(VA)
Research & Publications (20)
A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis.
PMID 19210273·Hemodial Int·2009
8-other
Efficacy and safety of fondaparinux and enoxaparin for acute coronary syndromes in CKD.
PMID 18436081·Am J Kidney Dis·2008
8-other
The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.
PMID 16793120·Thromb Res·2007
8-other
Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.
PMID 17880440·Haemophilia·2007
8-other
Use of enoxaparin in patients with chronic kidney disease: safety considerations.
PMID 17973538·Drug Saf·2007
6-review
Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal disease.
PMID 16420568·J Thromb Haemost·2006
8-other
The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapies.
PMID 16855073·J Clin Pharmacol·2006
3-trial
A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease.
PMID 15796773·Thromb J·2005
8-other
Darbepoetin alfa therapeutic interchange protocol for anemia in dialysis.
PMID 16189281·Ann Pharmacother·2005
4-observational
Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunction.
PMID 15304034·J Thromb Haemost·2004
8-other
Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time.
PMID 15264185·Am J Kidney Dis·2004
4-observational
Pharmacoeconomic considerations in the health system management of anaemia in patients with chronic kidney disease and end stage renal disease.
PMID 12943475·Expert Opin Pharmacother·2003
6-review
Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
PMID 12196069·Ann Pharmacother·2002
6-review
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.
PMID 11213853·Pharmacotherapy·2001
8-other
Cost-effectiveness of sevelamer versus calcium carbonate plus atorvastatin to reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosphatemia.
PMID 10939556·Pharmacotherapy·2000
4-observational
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers.
PMID 10722500·Antimicrob Agents Chemother·2000
3-trial
SCVIR annual meeting film panel session: diagnosis and discussion of case 2: Left hepatic arterioportal fistula.
PMID 11287546·J Vasc Interv Radiol·2001
5-case
Iatrogenic femoral pseudoaneurysms: thrombin injection after failed US-guided compression.
PMID 10644137·Radiology·2000
4-observational
SCVIR annual meeting film panel session: diagnosis and discussion of case 2.
PMID 10787214·J Vasc Interv Radiol·2000
5-case
Detected peritoneal fluid in small bowel obstruction is associated with the need for surgical intervention.
PMID 19503664·Can J Surg·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1250 E MARSHALL ST
RICHMOND, VA 23298 - Phone
- (804) 827-1455
Quick Facts
- NPI
- 1376621326
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile